Investigation of the effects of combine use of cisplatin and metformin on proliferation of prostate cancer cell lines and gstp, cyp17a1 and hexokinase II enzymes

Durukan, Özlem
Prostate cancer is the most common cancer type both in developed and developing countries. Since 2015, it has been seen as one of the main cause of death in males, both in the world and in our country. Current therapeutic approaches for prostate cancer generally have variable efficiency, develop metastasis and drug resistance, and have high toxicity to normal tissues. Hence, the searching for more effective strategies with moderate or any adverse effects for the chemopreventive intervention of those cancers remains one of the important issues in cancer research. Prostate cancer incidence and mortality vary dramatically by geographical location. Both are higher in developed countries. Some attribute this to westernized lifestyles of high energy diets and limited physical activity with consequent obesity. This dramatic increase in the incidence of cancer in overweight population suggests that there is a correlation between obesity and cancer. As a matter of fact, epidemiological and experimental research indicates that men with abdominal obesity is a risk factor for prostate cancer. Because in the case of obesity, people store plenty of glucose. Thus, cancer cells are more easily and quickly divide. According to this information, our aim in this study was reducing cell proliferation by reducing the blood glucose amount that passes from hepatic tissues by using metformin, a Type2 diabetes drug, hence provide the induction of cell death by creating oxidative stress in cells. Cisplatin, a cell division and growth inhibiting agent, is widely used in the treatment of prostate cancer. Cisplatin binds to DNA and forms a DNA adduct. This adduct cause the death of cancer cells by inhibiting transcription and or replication. Despite the high efficiency of cisplatin on prostate cancer treatment not only nephrotoxicity, neurotoxicity and gastrointestinal irritability but also azoospermia, oligospermia and infertility on reproductive age restrict the use of cisplatin. In order to reduce the side effects of cisplatin, combination therapy with other agents has been the focus of scientists in recent years. Considering the inducer effect of metformin, a type2 diabetic drug, on antiproliferative and apoptotic pathways it can provide a complementary treatment with antineoplastic agents, including cisplatin. GST family enzymes function in the detoxification of xenobiotics, including drugs. Becide, recently it is understood that GST s also function on cell proliferation and death that controls signal transduction. Carcinogenesis, differentiation, growth and important impact on drug resistance and cell death serve GST s as an important drug targets. GST family is also involved in prostaglandin, steroid and leukotriene biosynthesis. In addition, to determination of GTSP protein and gene expression to investigate the effect of combined treatment on the role of androgen synthesis, expression of CYP17A1 enzyme was determined in the cell lines. Furtermore, the effect of this combined treatment on hexokinase enzyme which plays an important role in the glycolysis pathway was investigated. Dose response of this combined therapy and cytotoxic effect of those drugs were measured by Alamar Blue assay. The effects of cisplatin and metformin on proliferation of cancer cell lines were detected by colony formation assay. Also, the effects of drugs on CYP17A1 GSTP and Hexokinase II enzymes will be detected by protein and mRNA expressions by using Western-Blot and qRTPCR techniques, respectively. IC50 value of cisplatin was determined as 17µM for LNCaP and 30 µM for PC3 cell line. The cell proliferation results showed that, metformin potentiates the antiproliferative effect of cisplatin both in LNCaP and PC3 cell lines. However, according to Western-blot and qPCR analysis, this reduction can not be blamed by GSTP enzymes. Expression of GSTP enzyme increased in direct proportion to dose of metformin. At this point, metformin may antagonize the cisplatin apoptotic effect through suppression of oxidative stress in prostate cancer cells. On the other hand, cisplatinmetformin drug combination significantly decreased the CYP17A1 protein expressions in PC3 cell lines. Furthermore, Hexokinase II mRNA expressions are significantly decrease in a dose dependent manner. In the treatment of cancer, which is frightening diseases of our century, combined therapy of diabetes based drugs with chemotherapeutic drugs will be helpful not only to reduce the toxicity of the of cisplatin, but also to reduce the cost.  


Cisplatin-Metformin ilaç kombinasyonu uygulamasının prostat hücre hatlarının proliferasyonu ve apoptoz mekanizmalarında önemli rol oynayan GST ile CYP17A1 ve Hekzokinaz enzimleri üzerine etkilerinin incelenmesi
Durukan, Özlem; Adalı, Orhan; Arslan, Şevki(2016)
Prostat kanseri, gelişmiş ve gelişmekte olan ülkelerde en sık görülen kanser türlerinden biri olup günümüzde prostat kanseri tedavisindeki yaklaşımlar metastaz gelişimine, ilaç direnci oluşmasına ve sağlıklı dokularda toksik etkilere sebep olabilmektedir. Bu nedenle tedavide daha etkili ancak daha az yan etkiye sahip kanser önleyici molekülleri tespit etmek kanser araştırmalarının önemli bir kısmını oluşturmaktadır. Cisplatin prostat kanseri tedavisinde sıklıkla kullanılan antineoplastik bir ajandır. Ancak,...
Relationship between the nat genetic polymorphism and susceptibility to prostate cancer
Dilek, Derya; Güray, Tülin; Department of Biology (2008)
Prostate cancer (PCa) is one of the most prevelant cancers in males in many countries, increasing in frequency with age. PCa incidence and mortality rates are not evenly distributed worldwide. Family history is an established risk factor for prostate cancer and families demonstrating autosomal dominant or X-linked transmission of susceptibility have been observed. Although an increasing number of candidate genes or hereditary prostate cancer susceptibility have been identified, only 5 to 10 percent of prost...
Characterization of liposomal celecoxib formulation as a drug delivery system in colorectal cancer cell lines
Erdoğ, Aslı; Banerjee, Sreeparna; Department of Biotechnology (2012)
Colorectal carcinoma (CRC) is one of the most common cancers and is the leading cause of cancer deaths in much of the developed world. Owing to the high incidence of drug resistance and potential toxic effects of chemotherapy drugs, much research is currently underway to design better strategies for smart drug delivery systems. Cyclooxygenase-2 (COX-2) pathway is associated with poor prognosis in colon carcinomas. The selective COX-2 inhibitor drug Celecoxib (CLX) has been shown to posses COX-2 independent ...
Comparison of the Diagnostic Accuracy of Next Generation Sequencing and Microarray Resequencing Methods for Detection of BRCA1 and BRCA2 Gene Mutations
Bahsi, Taha; Ergun, Sezen Güntekin; Ergun, Mehmet Ali; Perçin, E. Ferda (Gazi University, 2018-4-1)
Objective: Breast cancer constitutes 29 % of estimated new cases of cancer in women, and it is also one of the major cause of death in all cancer types. In this study, DNA samples of familial breast cancer patients with BRCA1 and BRCA2 mutations which had been analyzed using conventional DNA sequencing method, were also analyzed with new methods including microarray and next generation sequencing (NGS) in order to compare their results Methods: Seven patients with BRCA1 mutation, one patient with BRCA2 m...
Demirkaya, Damla; Gözen, Ayşe Gül; Antmen Altunsoy, Ezgi; Department of Molecular Biology and Genetics (2022-1-12)
Prostate cancer is the second most diagnosed cancer in men and relapse due to the metastasis of cancer cells is the main reason of the high number of deaths in prostate cancer patients. Thus, there is a growing need for a tumor model to study the prostate cancer metastasis. In this study, a 3D model consisting of two natural polymer hydrogels (methacrylated collagen and methacrylated hyaluronic acid) with tunable mechanical and chemical properties carrying spheroids of two different prostate cancer cell lin...
Citation Formats
Ö. Durukan, “Investigation of the effects of combine use of cisplatin and metformin on proliferation of prostate cancer cell lines and gstp, cyp17a1 and hexokinase II enzymes,” M.S. - Master of Science, Middle East Technical University, 2016.